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Reversible myocardial perfusion defect in a patient  
with anomalous origin of left circumflex coronary artery  
from right coronary sinus
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z nieprawidłowym odejściem gałęzi okalającej od prawej zatoki wieńcowej
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Abstract
We present the case of a 50 year-old woman with known anomalous origin of left circumflex coronary artery from 
the right sinus of Valsalva, with retro-aortic course confirmed by coronary computed tomography angiography. Due to 
progressive dyspnoea and a suspicion of ischaemia, the patient was referred to the Nuclear Medicine department for 
stress-rest myocardial perfusion scintigraphy. The imaging revealed inducible perfusion deficits mainly in the lateral and 
infero-lateral walls involving 14% of the total left ventricular (LV) myocardium. Although the detected coronary anomaly 
is considered nonmalignant, the extent of inducible ischaemia exceeding 10% of the LV myocardium should be taken 
into consideration while managing the patient. 
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Introduction
Coronary artery anomalies (CAAs) are a group of variable 
congenital disorders with diverse pathophysiological me-
chanisms and clinical manifestations [1]. The incidence 
of CAAs is approximately 0.3–0.9% in patients without 
structural abnormalities of the heart, but they are signifi-
cantly more frequent (3–36%) in patients with structural 
heart disease. Although in young athletes CAAs are the 
second most common cause of sudden cardiac death 
(SCD), in middle aged or elderly individuals they are very 
rarely fatal. The type of coronary anomaly most commonly 
associated with SCD is the anomalous origin of a coronary 
artery (AOCA), especially one with a course between the 
aorta and the pulmonary artery.
Case report
We present the case of a 50 year-old female with no history of 
coronary artery disease (CAD), with known anomalous origin 
of left circumflex (LCx) coronary artery from the right sinus 
of Valsalva, with retro-aortic course confirmed by coronary 
computed tomography angiography (CCTA) (Figures 1, 2). The 
patient was referred to the Nuclear Medicine department for 
stress-rest myocardial perfusion scintigraphy to assess the 
degree of suspected ischaemia due to progressive dyspnoea. 
Treadmill stress test was not performed because of total hip 
replacement and post-surgery insufficiency. Single-photon 
emission computed tomography (SPECT) was performed in 
a 1-day protocol, with dipyridamole stress test (0.56 mg/kg 
of body weight) and under rest conditions, one hour after 
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injection of 333 and 999 MBq of 99mTc-MIBI (methoxy-isobutyl-
-isonitrile), respectively. Imaging revealed inducible perfusion 
deficits in two regions: the larger one in the lateral and 
infero-lateral walls, and the smaller one in the anterior and 
antero-lateral walls, involving 14% of the total left ventricular 
(LV) myocardium (Figure 3). The patient was submitted to 
medical treatment with valsartan, amlodipine, and bisoprolol.
Discussion
Reversible ischaemia corresponding to limited coronary 
flow reserve (CFR) in the lateral and infero-lateral walls of 
the LV, the region supplied by LCx, most probably resulted 
from the anomalous origin of this artery. Although the 
detected coronary anomaly is generally considered nonma-
lignant and haemodynamically insignificant, an extent of 
inducible ischaemia exceeding 10% of the LV myocardium is 
associated with a high risk of cardiac death and myocardial 
infarct (annual mortality > 3%) [2], which should be taken 
into consideration while managing the patient. The smal-
ler reversible perfusion defect in the anterior (especially 
its apical segment) and the antero-lateral walls was most 
probably induced by myocardial bridging of the left anterior 
descending artery (LAD), also detected in CCTA.
It is worth pointing out that the patient was also diag-
nosed with mitochondrial myopathy with mutation of gene 
FBN1 (manifesting with muscle weakness), which could 
potentially influence the biokinetics of regional and/or global 
MIBI uptake in cardiomyocyte mitochondria [3–5]. MIBI is 
a cationic compound capable of passive diffusion into the 
cytoplasm and mitochondria and is trapped inside the mito-
chondria due to negative plasma and mitochondrial mem-
brane potentials. We did not observe disturbances in regional 
myocardial tracer uptake other than those described above. 
However, to quantitatively assess myocardial perfusion and 
to estimate the absolute value of myocardial blood flow (MBF) 
in mL/min/g in all LV segments, one should perform positron 
emission tomography (PET) [6]. When considering the appro-
priate perfusion tracer for cardiac PET scan in this case, one 
should avoid compounds which present with mitochondrial 
affinity, e.g. 18F-flurpiridaz [binds to mitochondrial complex 1 
(MC-1)], and choose between ligands with non-mitochondrial 
mechanisms of uptake, e.g. 82Rb (potassium analogue) or 
13N ammonia (freely diffusing agent, which gets trapped 
inside the cell after conversion through glutamine synthase 
to 13N-glutamine), or 15O water (freely diffusing agent).
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Figure 1A, B. Coronary computed tomography angiography (CCTA): cross-section (A) and 3-dimensional reconstruction (B) showing 
anomalous origin of left circumflex (LCx) coronary artery from right sinus of Valsalva with retro-aortic course; RCA — right coronary artery
Figure 2. Coronary computed tomography angiography (CCTA): 3-di-
mensional colour reconstruction showing precisely the anomalous 
origin of left circumflex (LCx) coronary artery from right sinus of 
Valsalva next to normal origin of the right coronary artery (RCA)
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Streszczenie
Prezentujemy przypadek 50-letniej kobiety z nieprawidłowym odejściem gałęzi okalającej od prawej zatoki wieńcowej 
z zaaortalnym przebiegiem potwierdzonym w angiotomografii komputerowej tętnic wieńcowych. Z powodu postępującej 
duszności i podejrzenia niedokrwienia mięśnia sercowego pacjentkę skierowano do zakładu medycyny nuklearnej 
w celu wykonania wysiłkowo-spoczynkowej scyntygrafii perfuzyjnej serca. Badanie obrazowe uwidoczniło odwracalne 
zaburzenia perfuzji głównie w ścianach dolnej i dolno-bocznej obejmujące 14% mięśnia lewej komory serca. Mimo że 
wykryta anomalia tętnic wieńcowych jest uznawana za łagodną, to zakres odwracalnego niedokrwienia przekraczający 
10% mięśnia lewej komory serca powinien być uwzględniony w trakcie postępowania z pacjentem. 
Słowa kluczowe: anomalia tętnic wieńcowych, indukowane niedokrwienie
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Figure 3A, B. Myocardial perfusion scintigraphy — single-photon emission computed tomography (SPECT): left ventricular (LV) slices (A), 
bull’s eyes (polar maps; B). Inducible perfusion deficits in lateral and infero-lateral walls, and in anterior and antero-lateral walls, involving 
14% of the total LV myocardium
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